27 min

226: Pharma's telehealth gold mine, the return of the biotech IPO, & a merger deferred The Readout Loud

    • Business

Our colleague Katie Palmer joins us to explain a burgeoning trend in pharmaceutical advertising that has health policy experts alarmed. We also discuss the White House's investment in biotech, a bellwether IPO, and the latest twist in the Merck-Seagen saga.

Our colleague Katie Palmer joins us to explain a burgeoning trend in pharmaceutical advertising that has health policy experts alarmed. We also discuss the White House's investment in biotech, a bellwether IPO, and the latest twist in the Merck-Seagen saga.

27 min

Top Podcasts In Business

NPR
iHeartPodcasts
Ramsey Network
Jocko DEFCOR Network
Guy Raz | Wondery
Andy Frisella #100to0